Judith Dierlamm

7.8k citations
111 papers · 4.1k indexed · 1 hit paper · h-index 33

Impact in

Papers in

    • Acute Myeloid Leukemia Research 23
    • Chronic Myeloid Leukemia Treatments 17
    • Chronic Lymphocytic Leukemia Research 29

Judith Dierlamm

107 papers receiving 4.0k citations

Hit Papers

The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas 1999 · 530 citations
5301999202620082017100200300400500

Peers

Judith Dierlamm
Comparison fields: 5 of 107
  • Genetics 1.3k
  • Pathology and Forensic Medicine 1.8k
  • Hematology 824
  • Oncology 1.3k
  • Cancer Research 599
Replace Eric Hedrick with:
Eric Hedrick United States
Ellen D. Remstein United States
Dieter K. Hossfeld Germany
Nicole Dastugue France
Christian Steidl Canada
Marı́a Rozman Spain
Margarita Sánchez‐Beato Spain
Roberto Giardini Italy
Juan Luis Garcı́a Spain
Pedro Jares Spain
Judith Dierlamm relative to Eric Hedrick United States Eric Hedrick's profile →
Citations per field
00.5×1.5×2.4×
Eric Hedrick · 1×
Citations per year

Countries citing papers authored by Judith Dierlamm

Since Specialization
Citations

This map shows the geographic impact of Judith Dierlamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Dierlamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Dierlamm more than expected).

Fields of papers citing papers by Judith Dierlamm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Dierlamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Dierlamm. The network helps show where Judith Dierlamm may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Judith Dierlamm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judith Dierlamm Line = papers co-authored together Judith Dierlamm links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 202414
3 20230
4 202214
5 202026
6 201113
7 20078
8
Dic (19;21) (p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome positive ALL.
20000
9 200037
10 19998
11
The t(11;18)(q21;q21) characterizes a subgroup of extranodal MALT lymphomas: a two-color fluor-escence in situ hybridization study using AP12 and MLT specific probes
19991
12
Amplification of chromosome 11q23 involving the MLL gene is recurrently observed in myeloid leukemias.
19981
13
Polysomy 13 with deletion of the retinoblastoma gene and the D13S25 locus in a case of acute myeloid leukemia
19981
14
Amplification of chromosome 11q.23 involving the MLL gene in a case of AML
19982
15 1997104
16
Successful use of the same slide for consecutive fluorescence in situ hybridization (FISH) experiments
199619
17
Chromosomal gains and losses in marginal zone B-cell lymphoma detected by comparative genomic hybridization
19961
18
Trisomy 13 in myeloid malignancies: Clinical, morphologic and immunologic correlations and characterization by combined immunophenotyping and interphase fluorescence in situ hybridization (FISH).
19962
19 199655
20 199465

About Judith Dierlamm

Judith Dierlamm is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Immunology, having authored 111 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (52 papers), Chronic Lymphocytic Leukemia Research (29 papers), Acute Myeloid Leukemia Research (23 papers), Viral-associated cancers and disorders (18 papers), Chronic Myeloid Leukemia Treatments (17 papers), Acute Lymphoblastic Leukemia research (14 papers), T-cell and Retrovirus Studies (8 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Genetics (1.3k citations), Pathology and Forensic Medicine (1.8k citations), Hematology (824 citations), Oncology (1.3k citations) and Cancer Research (599 citations). Judith Dierlamm has collaborated with scholars based in Germany, Belgium and Italy. Frequent co-authors include Iwona Włodarska, Herman Van den Berghe, Dieter K. Hossfeld, Peter Marynen, Anne Hagemeijer, Mathijs Baens, Lucienne Michaux, Christiane De Wolf‐Peeters, Jesús María Hernández‐Rivas and Manfred Stolte. Their work appears in journals such as Blood, Genes Chromosomes and Cancer, British Journal of Haematology, Haematologica and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026